Emerging Infections Program

T(ChDe CT)在HeeCalDthC‘ws ilElmpaertgicinipgateInfwecitihonthsePCroegnrtaemrs.中启用SS1e0e和DthePrarmatenstFTorheDilsoenags-eteCrmontorbojlecatnivdesPreovfetnhtison 该项目旨在为监测、预防和控制新发传染病提供国家资源 疾病。这将包括利用基于人口的监测和生态工业园结构的项目，以及 使其能够应对美国新的、新出现的和紧迫的传染病威胁。其他长期的 目标包括培训住院医生、研究员、公共卫生工作人员和实验室人员，并开发新的 预防策略。本5年筹资周期的具体目标包括监测重要的新出现的 侵袭性脑膜炎双球菌、肺炎双球菌等传染病。流感病毒与A、B群 链球菌感染以及食源性疾病，如E.cell O157：H7，沙门氏菌，志贺氏菌， 在以人口为基础的主动监测计划中，弯曲杆菌和李斯特菌随着时间的推移而变化。也是特定的 将开展应用公共卫生研究，包括评估新预防措施的影响 使用回顾队列对早发性B组链球菌感染率的建议 研究设计，对新型脑膜炎双球菌疫苗的疫苗效果进行病例对照研究， 完成婴幼儿弯曲杆菌和沙门氏菌感染病例对照研究的资料分析 描述收治重症社区获得性肺炎患者的流行病学和病原学 重症监护室。其他项目将包括开发提取医院出院信息的方法 下呼吸道感染的数据，对患流感的儿童的监测，以及 医院出院数据在识别格林-巴利综合征中的有用性评估。关于中国传统文化的几点思考 田纳西州不明原因脑炎的病因学研究 合作也将继续进行。田纳西州新发感染计划的项目 将提供重要的监测和研究成果，改善田纳西州人的健康，并为 作为监测和控制新发传染病的重要国家资源。

T(ChDe CT)enanedss1e0e oDtheprarstmatenst inofthHeeCalDthC'ws ilElmpaertgicinipgateInfwecitihonthsePCroegnrtaemrs. fTorheDilsoenags-eteCrmontorbojlecatnivdesPreovfetnhtison project are to provide a national resource for surveillance, prevention and control of emerging infectious diseases. This will include projects that utilize the population-based surveillance and structure of the EIP and allow it to address new, emerging and urgent infectious disease threats in the United States. Other long-term objectives include training residents, fellows, public health staff and laboratorians and developing new prevention strategies. Specific aims for this 5-year funding cycle include monitoring important emerging infectious diseases such as invasive meningococcal, pneumococcal, 1t. influenzae and groups A and B streptococcal infections as well as foodbome illnesses such as E. cell O157:H7, Salmonella, Shigella, Campylobacter and Listeria over time in a population-based active surveillance program. Also specific applied public health research will be undertaken including evaluating the impact of new prevention recommendations on the rates of early-onset group B streptococcal infections using a retrospective cohort study design, conducting a case-control study of vaccine effectiveness of the new meningococcal vaccine, completing data analysis of case-control studies of Campylobacter and Salmonella infections in infants and describing the epidemiology and etiology of severe community-acquired pneumonia in patients admitted to the intensive care unit. Other projects will include the development of methods to extract hospital discharge data for lower respiratory tract infections, surveillance for children admitted with influenza as well as an evaluation of the usefulness of hospital discharge data in identifying Guillain-Barr6 Syndrome. A study of the etiology of unexplained encephalitis in Tennessee utilizing state-of-the-art diagnostic testing and a three-state collaboration will also be continued. The projects planned for the Tennessee Emerging Infections Program will provide important surveillance and research results that will improve the health of Tennesseans and serve as an important national resource for monitoring and control of emerging infectious diseases.